---
figid: PMC6284860__oncotarget-09-36409-g001
figlink: /pmc/articles/PMC6284860/figure/F1/
number: F1
caption: In B cells, the balance of BCR activation initiation, amplitude and duration
  can be influenced by a specific immunoglobulin structure, adaptor molecules (e.g.
  GAB1, BLNK), kinases (e.g. LYN, SYK, BTK, PI3K) or phosphatases (e.g. SHIP1, SHP1
  and PTEN) activity and miRNAs levels. The cell-membrane proteins depicted in red
  represent the "negative" BCR pathway regulators (left part of the figure), and the
  cell-membrane proteins depicted in green represent the "positive" regulators (right
  part of the figure). The role of p53→miR-34a┤FOXP1 axis during DNA damage response
  and BCR signalling is highlighted in bold. The regulation of miRNA targets happens
  at the mRNA stability and/or translation level, which is not visualized here. Direct
  miRNA transcription regulation by transcription factors in the nucleus is depicted.
  The sharp point arrow indicates activation; the blunt-end arrow indicates repression.
pmcid: PMC6284860
papertitle: 'p53 limits B cell receptor (BCR) signalling: a new role for miR-34a and
  FOXP1.'
reftext: Katerina Cerna, et al. Oncotarget. 2018 Nov 23;9(92):36409-36410.
pmc_ranked_result_index: '18772'
pathway_score: 0.9570793
filename: oncotarget-09-36409-g001.jpg
figtitle: 'p53 limits B cell receptor (BCR) signalling: a new role for miR-34a and
  FOXP1'
year: '2018'
organisms: Homo sapiens
ndex: 1afc86a5-dee7-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6284860__oncotarget-09-36409-g001.html
  '@type': Dataset
  description: In B cells, the balance of BCR activation initiation, amplitude and
    duration can be influenced by a specific immunoglobulin structure, adaptor molecules
    (e.g. GAB1, BLNK), kinases (e.g. LYN, SYK, BTK, PI3K) or phosphatases (e.g. SHIP1,
    SHP1 and PTEN) activity and miRNAs levels. The cell-membrane proteins depicted
    in red represent the "negative" BCR pathway regulators (left part of the figure),
    and the cell-membrane proteins depicted in green represent the "positive" regulators
    (right part of the figure). The role of p53→miR-34a┤FOXP1 axis during DNA damage
    response and BCR signalling is highlighted in bold. The regulation of miRNA targets
    happens at the mRNA stability and/or translation level, which is not visualized
    here. Direct miRNA transcription regulation by transcription factors in the nucleus
    is depicted. The sharp point arrow indicates activation; the blunt-end arrow indicates
    repression.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - PIK3CG
  - PIK3CD
  - BCR
  - PIK3R3
  - BTK
  - MS4A1
  - CD22
  - FCGR2B
  - PIK3R4
  - FOXP1
  - GAB1
  - LYN
  - MYB
  - MYC
  - NFKB1
  - NFKB2
  - BLNK
  - RELB
  - CD19
  - PIK3R6
  - PIK3R5
  - SYK
  - PIK3CA
  - PIK3CB
  - PLCG2
  - PTEN
  - INPP5D
  - TP53
  - RELA
  - PTPN6
  - REL
  - Cancer
genes:
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: BCR
  symbol: BCR
  source: hgnc_symbol
  hgnc_symbol: BCR
  entrez: '613'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: BTK
  symbol: BTK
  source: hgnc_symbol
  hgnc_symbol: BTK
  entrez: '695'
- word: CD20
  symbol: CD20
  source: hgnc_prev_symbol
  hgnc_symbol: MS4A1
  entrez: '931'
- word: CD22
  symbol: CD22
  source: hgnc_symbol
  hgnc_symbol: CD22
  entrez: '933'
- word: FCGRIIB
  symbol: FCGR2B
  source: hgnc_symbol
  hgnc_symbol: FCGR2B
  entrez: '2213'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: FOXP1
  symbol: FOXP1
  source: hgnc_symbol
  hgnc_symbol: FOXP1
  entrez: '27086'
- word: GAB1
  symbol: GAB1
  source: hgnc_symbol
  hgnc_symbol: GAB1
  entrez: '2549'
- word: LYN
  symbol: LYN
  source: hgnc_symbol
  hgnc_symbol: LYN
  entrez: '4067'
- word: MYB
  symbol: MYB
  source: hgnc_symbol
  hgnc_symbol: MYB
  entrez: '4602'
- word: MYC
  symbol: MYC
  source: hgnc_symbol
  hgnc_symbol: MYC
  entrez: '4609'
- word: NFKB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: NFKB1
  entrez: '4790'
- word: NFKB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: NFKB2
  entrez: '4791'
- word: BLNK
  symbol: BLNK
  source: hgnc_symbol
  hgnc_symbol: BLNK
  entrez: '29760'
- word: NFKB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: RELB
  entrez: '5971'
- word: CD19
  symbol: CD19
  source: hgnc_symbol
  hgnc_symbol: CD19
  entrez: '930'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: SYK
  symbol: SYK
  source: hgnc_symbol
  hgnc_symbol: SYK
  entrez: '6850'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: PLCY2
  symbol: PLCG2
  source: hgnc_symbol
  hgnc_symbol: PLCG2
  entrez: '5336'
- word: PTEN
  symbol: PTEN
  source: hgnc_symbol
  hgnc_symbol: PTEN
  entrez: '5728'
- word: SHIP1
  symbol: SHIP1
  source: hgnc_alias_symbol
  hgnc_symbol: INPP5D
  entrez: '3635'
- word: p53
  symbol: p53
  source: hgnc_alias_symbol
  hgnc_symbol: TP53
  entrez: '7157'
- word: NFKB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: RELA
  entrez: '5970'
- word: (SHP1
  symbol: SHP-1
  source: hgnc_alias_symbol
  hgnc_symbol: PTPN6
  entrez: '5777'
- word: NFKB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: REL
  entrez: '5966'
chemicals: []
diseases:
- word: Cancer
  source: ''
  identifier: ''
figid_alias: PMC6284860__F1
redirect_from: /figures/PMC6284860__F1
figtype: Figure
---
